#BEGIN_DRUGCARD DB03340

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C7H14NO6P

# Chemical_IUPAC_Name:
(2R)-3-{[(1S)-1-amino-2-carboxyethyl](hydroxy)phosphoryl}-2-methylpropanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
3-[(1-Amino-2-Carboxy-Ethyl)-Hydroxy-Phosphinoyl]-2-Methyl-Propionic Acid

# HET_ID:
AEP

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C7H14NO6P/c1-4(7(11)12)3-15(13,14)5(8)2-6(9)10/h4-5H,2-3,8H2,1H3,(H,9,10)(H,11,12)(H,13,14)/t4-,5-/m0/s1

# InChI_Key:
InChIKey=NJOTXUMMTTYQMQ-WHFBIAKZSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3340

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
239.1629

# Molecular_Weight_Mono:
239.055873697

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1LFW

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.4

# Predicted_LogS:
-0.92

# Predicted_Water_Solubility:
2.90e+01 g/l

# Primary_Accession_No:
DB03340

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936646

# PubChem_Substance_ID:
46507034

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00448

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
C[C@@H](C[P@@](O)(=O)[C@H](N)CC(O)=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:09 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Z31377

# Drug_Target_1_GenBank_ID_Protein:
577569

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
pepV

# Drug_Target_1_Gene_Sequence:
>1413 bp
ATGGACTTAAACTTTAAAGAACTGGCGGAAGCCAAGAAGGACGCGATCTTAAAAGACTTA
GAGGAATTGATCGCCATTGACTCTTCAGAAGACCTGGAAAACGCCACGGAAGAATACCCA
GTTGGCAAGGGTCCGGTTGACGCCATGACCAAGTTCCTCAGCTTTGCCAAGCGGGACGGC
TTTGACACGGAAAACTTCGCCAACTACGCCGGCCGGGTCAACTTCGGTGCAGGCGACAAG
CGCCTGGGCATCATCGGCCACATGGACGTAGTGCCAGCTGGTGAAGGCTGGACCCGGGAC
CCCTTCAAGATGGAAATCGACGAAGAAGGCCGGATCTACGGCCGGGGCAGCGCCGACGAC
AAGGGGCCAAGCTTAACTGCCTACTACGGGATGCTTTTGCTCAAAGAAGCTGGCTTTAAG
CCAAAGAAGAAGATCGACTTCGTCTTAGGGACCAACGAAGAAACCAACTGGGTCGGGATC
GACTACTACTTGAAGCACGAACCGACTCCAGACATCGTCTTCTCACCAGACGCTGAATAC
CCGATCATCAATGGTGAACAAGGGATCTTCACCCTGGAATTCAGCTTCAAGAACGATGAT
ACTAAGGGCGACTATGTTTTAGACAAGTTCAAGGCCGGGATTGCCACTAACGTGACTCCG
CAGGTTACCCGGGCTACTATCTCTGGACCTGACCTGGAAGCTGTTAAATTGGCTTACGAA
AGCTTTTTGGCAGACAAGGAATTGGACGGATCATTTGAAATTAATGACGAAAGCGCCGAT
ATCGTCTTGATCGGCCAAGGGGCCCACGCTTCAGCTCCGCAAGTCGGCAAGAACTCAGCA
ACCTTCCTGGCCCTCTTCCTGGACCAATACGCTTTTGCCGGCCGGGACAAGAACTTCCTC
CACTTCCTGGCTGAAGTGGAACACGAAGACTTCTATGGCAAGAAGCTGGGCATCTTCCAC
CACGATGATCTGATGGGCGATCTGGCCAGCAGCCCGTCCATGTTCGACTACGAACACGCC
GGCAAGGCCAGCCTCTTGAACAATGTCCGCTACCCGCAAGGGACTGACCCGGACACCATG
ATCAAGCAGGTTCTGGACAAGTTCAGCGGCATCCTGGATGTCACTTACAACGGCTTTGAA
GAACCGCACTACGTGCCAGGCAGCGACCCAATGGTGCAGACTTTGCTCAAGGTTTACGAA
AAACAAACCGGCAAGCCGGGCCACGAAGTCGTAATCGGCGGCGGGACTTACGGCCGCCTC
TTTGAGCGCGGGGTTGCCTTCGGGGCCCAGCCGGAAAACGGCCCAATGGTTATGCACGCC
GCCAACGAATTCATGATGCTGGACGATTTGATCCTGTCCATCGCTATCTACGCTGAAGCC
ATCTACGAATTGACCAAGGACGAAGAGCTGTAA

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
7528082	Vongerichten KF, Klein JR, Matern H, Plapp R: Cloning and nucleotide sequence analysis of pepV, a carnosinase gene from Lactobacillus delbrueckii subsp. lactis DSM 7290, and partial characterization of the enzyme. Microbiology. 1994 Oct;140 ( Pt 10):2591-600.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2917

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
51991

# Drug_Target_1_Name:
Beta-Ala-Xaa dipeptidase

# Drug_Target_1_Number_of_Residues:
470

# Drug_Target_1_PDB_ID:
1LFW

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01546	Peptidase_M20

# Drug_Target_1_Protein_Sequence:
>Beta-Ala-Xaa dipeptidase
MDLNFKELAEAKKDAILKDLEELIAIDSSEDLENATEEYPVGKGPVDAMTKFLSFAKRDG
FDTENFANYAGRVNFGAGDKRLGIIGHMDVVPAGEGWTRDPFKMEIDEEGRIYGRGSADD
KGPSLTAYYGMLLLKEAGFKPKKKIDFVLGTNEETNWVGIDYYLKHEPTPDIVFSPDAEY
PIINGEQGIFTLEFSFKNDDTKGDYVLDKFKAGIATNVTPQVTRATISGPDLEAVKLAYE
SFLADKELDGSFEINDESADIVLIGQGAHASAPQVGKNSATFLALFLDQYAFAGRDKNFL
HFLAEVEHEDFYGKKLGIFHHDDLMGDLASSPSMFDYEHAGKASLLNNVRYPQGTDPDTM
IKQVLDKFSGILDVTYNGFEEPHYVPGSDPMVQTLLKVYEKQTGKPGHEVVIGGGTYGRL
FERGVAFGAQPENGPMVMHAANEFMMLDDLILSIAIYAEAIYELTKDEEL

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Is a relatively unspecific dipeptidase cleaving a variety of dipeptides, notably those with an N-terminal beta-Ala or D-Ala residue, e.g. carnosine (beta-Ala-His). To a lesser extent, also shows aminopeptidase activity, since it is able to catalyze the removal of the N-terminal amino acid from a few distinct tripeptides

# Drug_Target_1_SwissProt_ID:
P45494

# Drug_Target_1_SwissProt_Name:
PEPV_LACDL

# Drug_Target_1_Synonyms:
Beta-Ala-His dipeptidase
EC 3.4.13.-
Peptidase V

# Drug_Target_1_Theoretical_pI:
4.31

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB03340
